MaxCyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MaxCyte and other ETFs, options, and stocks.About MXCT
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing.
CEOMaher Masoud
CEOMaher Masoud
Employees114
Employees114
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded1998
Founded1998
Employees114
Employees114
MXCT Key Statistics
Market cap158.41M
Market cap158.41M
Price-Earnings ratio-3.42
Price-Earnings ratio-3.42
Dividend yield—
Dividend yield—
Average volume2.12M
Average volume2.12M
High today$1.53
High today$1.53
Low today$1.48
Low today$1.48
Open price$1.48
Open price$1.48
Volume206.02K
Volume206.02K
52 Week high$5.20
52 Week high$5.20
52 Week low$1.26
52 Week low$1.26
Stock Snapshot
With a market cap of 158.41M, MaxCyte(MXCT) trades at $1.49. The stock has a price-to-earnings ratio of -3.42.
On 2025-12-17, MaxCyte(MXCT) stock traded between a low of $1.48 and a high of $1.53. Shares are currently priced at $1.49, which is +0.3% above the low and -2.9% below the high.
The MaxCyte(MXCT)'s current trading volume is 206.02K, compared to an average daily volume of 2.12M.
During the past year, MaxCyte(MXCT) stock moved between $1.26 at its lowest and $5.20 at its peak.
During the past year, MaxCyte(MXCT) stock moved between $1.26 at its lowest and $5.20 at its peak.
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%
People also own
Based on the portfolios of people who own MXCT. This list is generated using Robinhood data, and it’s not a recommendation.